Navigation
Suscribe
Menu Search Facebook Twitter
Search Close
Menu ALL SECTIONS
  • Capital Coahuila
  • Capital Hidalgo
  • Capital Jalisco
  • Capital Morelos
  • Capital Oaxaca
  • Capital Puebla
  • Capital Quintana Roo
  • Capital Querétaro
  • Capital Veracruz
  • Capital México
  • Capital Michoacán
  • Capital Mujer
  • Reporte Índigo
  • Estadio Deportes
  • The News
  • Efekto
  • Diario DF
  • Capital Edo. de Méx.
  • Green TV
  • Revista Cambio
Radio Capital
Pirata FM
Capital Máxima
Capital FM
Digital
Prensa
Radio
TV
X
Newsletter
Facebook Twitter
X Welcome! Subscribe to our newsletter and receive news, data, statistical and exclusive promotions for subscribers
World

Ex-Drug Exec Shkreli Pleads Not Guilty to Latest Charge

Prosecutors on Friday added an eighth charge, saying Shkreli tried to conceal from investors his control over shares in Retrophin Inc.

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs following a hearing at U.S. Federal Court in New York, photo: Reuters/Lucas Jackson
By Reuters Whatsapp Twitter Facebook Share
1 year ago

NEW YORK — Former pharmaceutical executive Martin Shkreli, a lightning rod for outrage over soaring U.S. prescription drug prices, pleaded not guilty on Monday to an additional criminal charge that federal prosecutors filed against him last week.

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, winks as he arrives at U.S. Federal Court in New York, U.S., June 6, 2016. Photo: Reuters/Lucas Jackson

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, winks as he arrives at U.S. Federal Court in New York, U.S., June 6, 2016. Photo: Reuters/Lucas Jackson

Shkreli, 33, was indicted in December on seven criminal counts, including securities fraud. Prosecutors on Friday added an eighth charge, saying Shkreli tried to conceal from investors his control over shares in Retrophin Inc.

Evan Greebel, former outside counsel to Retrophin, also pleaded not guilty to the charge at a court hearing in the New York City borough of Brooklyn. Greebel faces two counts in all.

Shkreli last year sparked outrage among patients, medical societies and U.S. lawmakers after another company he ran, Turing Pharmaceuticals, raised the price of Daraprim by more than 5,000 percent to $750 a pill.

In December, U.S. authorities arrested him on fraud charges unrelated to the pricing of Daraprim, saying he ran his investment funds and companies almost like a Ponzi scheme.

U.S. District Judge Kiyo Matsumoto declined during Monday’s hearing to set a trial date for Shkreli and Greebel but said she was considering an early 2017 time frame.

DAVID INGRAM

Comments Whatsapp Twitter Facebook Share
More From The News
Mexico

Mexico Quake Rescuers Race to Free Girl, ...

3 hours ago
World

Battle against I.S. in Raqqa is in 'Fina ...

4 hours ago
Mexico

Soft Soil Makes Mexico City Shake Like i ...

4 hours ago
Mexico

Mexican Red Cross Providing Assistance f ...

5 hours ago
Most Popular

7.1 Magnitude Quake Kills 139 as Buildui ...

By The Associated Press
Mexico

Mexicans Dig through Collapsed Buildings ...

By The Associated Press
Mexico

Rescuers Wriggle into Collapsed School a ...

By The Associated Press
Mexico

TUSGS Says Mexico Quake Magnitude 7.1

By The Associated Press
Mexico

Mancera Pays Tribute to 85 Earthquake in ...

By Notimex
Mexico